Massachusetts biopharmaceutical company developing therapies for neurogenic inflammation, including chronic cough and pain.
Nocion Therapeutics, Inc., founded in 2017 by Bruce Levy MD, Clifford Woolf Ph.D and Bruce Bean Ph.D, is based in Massachusetts, US. Its therapies target neurogenic inflammation conditions such as chronic cough, pain, itch and inflammation, and it is also developing treatments in pulmonology, gynecology, urology, dermatology, gastroenterology and ophthalmology. In February 2024 it raised USD 31.11 million in Series B funding co-led by Arkin Holdings and Monograph Capital Partners.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in